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It is well established that Ebola Survivors experience a myriad of physical and psychological
sequelae. However, little is known about how they seek care to address their health needs.
Our study determines the current healthcare seeking behaviour among Ebola survivors and
determines the prevalence, pattern of use and correlates of traditional and complementary
medicine (T&CM) use among Ebola survivors in Sierra Leone.
Methods
We conducted a nationwide questionnaire survey among a cross-sectional sample of Ebola
Survivors in Sierra Leone between January and August 2018. We employed descriptive sta-
tistics, chi-square test, Fisher exact two-tailed test and backward stepwise binary regression
analysis for data analysis. A p-value less than 0.05 was considered statistically significant.
Results
Ebola Survivors who participated in our study (n = 358), visited a healthcare provider (n =
308, 86.0%), self-medicated with conventional medicines (n = 255, 71.2%) and visited a pri-
vate pharmacy outlet (n = 141, 39.4%). Survivors also self-medicated with T&CM products
(n = 107, 29.9%), concurrently self-medicated with conventional and T&CM products (n =
62, 17.3%), and visited a T&CM practitioner (n = 41, 11.5%). Almost half of (n = 163, 45.5%)
Ebola survivors reported using T&CM treatments for post ebola related symptoms and non-
Ebola related symptoms since their discharge from an Ebola treatment centre. Ebola survi-
vors who considered their health to be fair or poor (AOR = 4.08; 95%CI: 2.22–7.50; p<0.01),
presented with arthralgia (AOR = 2.52; 95%CI: 1.11–5.69, p = 0.026) and were discharged
three years or less (AOR = 3.14; 95%CI: 1.13–8.73, p = 0.028) were more likely to use
T&CM. Family (n = 101,62.0%) and friends (n = 38,23.3%) were the common sources of
T&CM information. Abdominal pain (n = 49, 30.1%) followed by joint pain (n = 46, 28.2%)
and back pain (n = 43, 26.4%) were the most cited post–Ebola indications for T&CM use.
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More than three-quarters of T&CM users (n = 135, 82.8%) failed to disclose their use of
T&CM to their healthcare providers.
Conclusion
Ebola survivors in Sierra Leone employ a myriad of healthcare options including T&CM in
addressing their healthcare needs. Researchers, health policy makers and healthcare pro-
viders should be aware of the substantial role of T&CM in the health seeking of survivors,
and this topic that should be factored into future research, policy formulation and implemen-
tation as well as routine practice regarding Ebola survivors.
Introduction
Traditional and complementary medicine (T&CM) consists of numerous health products and
practices (either originating within or outside of local native cultures) not traditionally con-
nected with the conventional healthcare system and dominant medical profession.[1] Globally,
interest in and use of T&CM either via self-medication or services provided by T&CM practi-
tioners, has grown rapidly.[1] In Africa, a considerable number of the population use T&CM
alone or in combination with conventional medicine to address their health needs even in
instances where there is lack of scientific evidence to support the safety and efficacy of the ther-
apy.[1, 2] The key reported drivers responsible for the high use of T&CM in Africa include
perceived low relative cost; alignment with cultural, religious and spiritual values; and disen-
chantment with biomedicine.[2] T&CM use is considered a public health and health service
issue as it presents opportunities and challenges for the provision of primary healthcare for
many in low to mid-income countries.[1] In Sierra Leone, T&CM use is reported to be wide-
spread especially among pregnant women[3], lactating mothers[4] hypertensive patients[5],
infertile women[6] and for the treatment of malaria among children[7, 8] and adults.[9]
The increased incidence of emerging (e.g. Ebola, Zika and Severe acute respiratory synticial
syndrome (SARS)) and re-emerging (malaria and tuberculosis) infectious diseases is linked to
a range of biological, ecological, political and socioeconomic factors, and is considered a threat
to global health security.[10, 11] In low-income countries, where health systems are often
under-resourced and where medical pluralism (the use of both conventional and T&CM for
health and illness) is rife[2, 12] emerging and re-emerging infectious diseases account for
approximately half of all deaths.[13]. Due to widespread resistance to antimicrobials employed
to treat emerging and re-emerging disease pathogens and associated safety concerns, there has
been heightened public interest in T&CM to treat infectious diseases–supported by the percep-
tion that these therapies and treatments are natural and safe.[14] For instance, traditional Chi-
nese medicine formulae that is made up of American ginseng Radix Adenophorae Strictae,
Radix Ophiopognis, Radix Bupleuri, Radix Scutellariae, mulberry leaf, Cortex Lycii, Radicis,
Herba Artemisiae, Rhizoma Phragmitis, Radix, Angelicae Sinensis, Radix Paeoniae Alba and
Rhizoma Pinelliae have been used to treat patients with SARS[15]. While there are reports of
T&CM use in SARS and Zika virus disease management,[16, 17] the extent and outcome of
T&CM utilization among Ebola patients and survivors have received little or no research
attention since the discovery of the disease.
The West African Ebola Virus disease (EVD) outbreak is described as the largest and most
devastating health emergency the world has witnessed in the history of the EVD. As of 2016,
the virus had infected over 28, 000 people and caused 11,310 deaths in the three most affected
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countries West African countries: Guinea, Liberia and Sierra Leone[18]. The Ebola outbreak
in West Africa also recorded the maximum number of survivors of the disease to date. Over
7000 individuals in Guinea, Liberia and Sierra Leone were estimated to have survived EVD in
2016[19] and it is well established that in addition to the psychological trauma experienced
during admission, most survivors present with immediate and long term physical and mental
complications post-discharge[20–22]. Currently, there are fewer reports on the involvement of
T&CM during Ebola outbreaks in Africa. These reports serve to highlight T&CM role in EVD
transmission and prevention without offering a deeper insight into its pattern of use and or
impact.[23–25] Preliminary unpublished data from Sierra Leone suggests EVD survivors
experiencing long-term physical and psycho-social problems seek the services of traditional
healers.[26] Such health seeking relating to T&CM may be due to personal, economic, psycho-
logical, social and cultural needs as well as health system factors. However, vigorous, large-
scale studies are needed to determine the extent to which this initial report can be confirmed
and representative of the wider population of Ebola survivors. In light of the common use of
T&CM in Sierra Leone,[3, 5, 6] and the interest among the scientific community in under-
standing post-Ebola sequelae among survivors,[27] there is a significant gap in our understand
of the role of T&CM in addressing the health needs of Ebola survivors (within the wider land-
scape of their health seeking behaviours). In direct response, the study reported here aims to
determine the current healthcare seeking behaviour among Ebola survivors suffering from
post-Ebola complications including an examination of the prevalence, pattern of use and cor-
relates of T&CM use among Ebola survivors in Sierra Leone.
Materials and methods
Study setting, design, and participants
Sierra Leone is a low-income West African country with a population of 7million inhabitants
and a land size of approximately 71,740 km2 [28].It borders Guinea in the northeast and Libe-
ria in the Southeast. Sierra Leone is divided into four administrative regions (northern, south-
ern, eastern provinces as well as the western area) and 14 districts. Despite substantial
investment in the health sector, Sierra Leone still host to the worst health indicators, and the
decline in the overall health status was excercebated by the 11years protracted civil war that
ended in 2002, and the recent 2014–2016 Ebola outbreak. Whilst life expectancy at birth for
males and females is currently at 52 years, maternal, infant and neonatal morbidity and mor-
tality remain one of the highest in the world[29]. The health workforce is also limited with
recent report estimating that there are 1.4 healthcare providers (doctor, nurses and midwives)
per 10000 population[30].
A cross-sectional nationwide study was conducted between January and August 2018 among
Ebola survivors residing five districts across all four geographic regions (Western Area, North-
ern Province, Eastern Province and Southern Province) of Sierra Leone. Fig 1 shows the loca-
tions of the five districts in Sierra Leone and they include western area urban and western area
rural districts (both in the Western area), Bo district (Southern province), Kenema district
(Eastern province) and Bombali district (Northern province). These districts were chosen based
on the epidemiological profile of the total confirmed Ebola cases and because they are host to
the highest number of Ebola survivors in Sierra Leone across all four geographic regions[31].
Male and female adult (at least 18years old) Ebola survivors with varied socio-demographic and
health related characteristics experiencing post-Ebola sequelae were recruited into the study.
Ebola Survivor status was confirmed by the presentation of their Ebola discharge certificates.
Given that majority of Ebola survivors (76%-90%) of are experiencing post–Ebola symptoms
[32, 33], determination of post-Ebola sequelae was based on EVD survivors’ self report of signs
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and or symptoms that occurred only after surviving the EVD. We excluded Ebola Survivors
who presented with post-Ebola complications that seriously challenged their ability to accu-
rately provide information or participate in the study. Examples include memory loss, hearing
loss, high fever and bleeding or those experiencing acute emotional distress that will put the
research team and study participants at risk. During recruitment, Ebola survivors were screened
for acute emotional distress using a screening guide (S1 File) adapted from Draucker et al[34].
Ebola survivors were asked whether they are experiencing any form of emotional distress that is
getting in the way of them doing their normal daily activities (school, work, family, and other
obligations or whether they having thoughts of harming themselves or others.
Sampling strategy
We determined the sample size based on the formula for sample size calculation for cross-sec-
tional studies. We used a prevalence of 50% since no previous study has determined the preva-
lence of use of T&CM in this patient cohort. In this case, we assumed that 50% of the 4051[19]
registered survivors in Sierra Leone would have used T&CM and with a confidence level of 95%
and margin of error 5%, a minimum sample of 351 Ebola Survivors experiencing post-Ebola
complications was calculated. To increase our statistical power, 400 survivors were invited to
participate, but only 377 consented. Ebola survivors were sampled from five districts across all
four geographical regions of Sierra Leone. For each district, the headquarter town was chosen as
an urban settlement alongside a nearby rural setting which was chosen randomly from the rural
settings located around the urban area. Simple random sampling was employed to recruit survi-
vors in each of the five districts. The number of survivors targeted in each of the four regions
was determined by proportional representation. EVD survivors were recruited via was done
through telephone using the Sierra Leone Association of Ebola Survivors’ national database.
Study questionnaire
A structured questionnaire (S2 File) was developed based on the reviewed literature.[2, 3, 20, 21]
The final version of the questionnaire was informed by feedback from the pilot study conducted
among 10 Ebola survivors whose data was not included in the final analysis and insights from a
group of local experts (epidemiologist, pharmacologist, an infectious disease specialist and a
Fig 1. Locations of the five districts in Sierra Leone.
https://doi.org/10.1371/journal.pone.0223068.g001
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physician providing care to Ebola survivors). The questionnaire had three domains. The first
domain examined participant demographics and health related characteristics, the second
focused upon health seeking behaviour, T&CM and products utilisation, information sources
about T&CM and disclosure of T&CM to healthcare providers. The third domain explored
Ebola survivors’ attitudes towards T&CM in which they were asked whether they agreed or dis-
agreed with certain statements. Examples of the attitude statements include T&CM has fewer
side effects than conventional medicine (CM), T&CM is more natural than CM and T&CM pro-
motes a holistic approach to health. Four trained research assistants from the University of Sierra
Leone were employed to help administer the questionnaire. After explaining the purpose of the
study to all consented participants, data were collected via self-administered format for those
that were literate or via face-to-face interviewer-administered format for those who were illiter-
ate. Data collection took place at the Sierra Leone Association of Ebola Survivors regional offices
or at EVD survivors’ homes where they were handed the questionnaires. Our conceptualisation
of T&CM included biological based therapy (herbal medicine and animal extract), spiritual ther-
apy (prayer/faith healing), alternative medicine systems (Chinese herbal medicine, and acupunc-
ture), and physical therapy/body manipulations (massage therapy, traditional bone setting).
Ethical consideration
We obtained ethical approval (see attached) for the study from the University of Technology
Sydney Human Research Ethics Committee (UTS-HREC-ETH17-2080). We also obtained a
reciprocal ethical clearance from the Sierra Leone Ethics and Scientific Review Committee
(SLESRC). A written patient information and consent form explaining the purpose and scope
of the study as well as the option of opting out if survivors felt uncomfortable at any time dur-
ing the interview was provided to each recruited participant. For those who were illiterate, the
purpose and scope of the study were explained in Creole (–widely spoken language in Sierra
Leone) before obtaining their consent to participate. Signing and thumb printing (for illiterate
participants) the consent form was taken as an expression of their willingness to participate.
Verbal consent from community leaders/elders and written approval from local healthcare
authorities were also sought prior to commencing the study.
Data analysis
We used IBM SPSS Statistics version 24 to analyse our data. We recoded relevant independent
variables to assist effective data analysis and interpretation. We used descriptive statistics to
calculate frequencies and percentages for categorical variables and mean standard deviation
for continuous independent variables. Chi-square and Fischer exact two-tailed tests were used
to determine the associations between demographic variables (independent variables) and
T&CM treatment use (dependent variable). We defined T&CM treatment use in our study as
the use of the any of the T&CM modalities since discharge from Ebola treatment centre in at
least one of the following scenarios, self-use of T&CM, concomitant self-use of T&CM and
conventional medicines, visit to a religious leader/faith healer for healing and visit to tradi-
tional medicine practitioner (native doctor, herbalist). We employed backwards stepwise
binary logistic regression to control for confounding and to establish the most parsimonious
model that predicts the likelihood of T&CM treatment use. Significance level of the p-value
was considered at 0.05.
Results
Out of 377 EVD survivors who consented to participate in the study, 19 failed to complete the
questionnaire resulting in 358 participants in the final dataset.
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Participant characteristics
Table 1 summarises EVD survivors’ demographic and health-related characteristics. The
majority of participants were below the age of 42years (n = 276, 77.7%) and Muslim (n = 266,
74.3%). Approximately two-thirds were females (n = 223, 62.3%) and reported a monthly
income of less than Le500, 000 (US$ 64.1). Arthralgia (n = 319, 89.1%) and headache (n = 272,
76.0%) were the common post-Ebola symptoms among EVD survivors.
Conventional and T&CM health service utilisation among EVD survivors
EVD survivors conventional and T&CM health-seeking behaviour since discharge from ETC
are reported in Table 2; 308 survivors (86.0%) visited a healthcare provider (doctor, nurse at
hospital, Ebola Survivor clinic etc.) while 255(71.2%) and self-medicated with conventional
medicines and 141(39.4%) visited a private pharmacy outlet. Meanwhile, 107(29.9%), 62
(17.3%) and 41(11.5%) self-medicated with T&CM product, self-used both conventional and
T&CM concurrently and visited T&CM practitioner respectively. Close to three-quarters of
EVD survivors who self-medicated with conventional medicines (191/255) and half of EVD
survivors who self-medicated with T&CM product (54/107) or who concurrently self-medi-
cated with both conventional and T&CM product, (31/62) reported doing so to treat their
post-Ebola symptoms. Meanwhile, the majority of EVD survivors that visited a hospital/clinic
(251/308), or visited a traditional medicine practitioner (30/41) did so to seek a complete cure
for their Ebola sequelae. Slightly over half of EVD survivors that sought care at a private phar-
macy (75/141) and close to two-thirds of EVD survivors who visited a faith/religious healer
(47/73) did so to be completely cured from their post-Ebola symptoms.
Characteristics of T&CM users
The bivariate association between T&CM and demographic and health-related variables are
reported in Table 3. Educational Status (p = 0.045), region (p<0.001), current perceived health
status (p<0.001) and duration (months) since discharged from Ebola treatment centre
(p = 0.022) show significant associations between T&CM users and non- T&CM users. The
results of the backwards stepwise binary logistic regression are shown in Table 4 and it
revealed that EVD survivors who considered their health to be fair or poor (AOR = 4.08; 95%
CI: 2.22–7.50; p<0.01), presented with arthralgia (AOR = 2.52; 95%CI: 1.11–5.69, p = 0.026)
and were discharged three years or less (AOR = 3.14; 95%CI: 1.13–8.73, p = 0.028) were more
likely to use T&CM.
Pattern of T&CM utilisation
Table 5 describes the pattern of T&CM treatment use among users. A total of 163 (45.5%)
EVD survivors reported using a T&CM product and/or a T&CM practitioner since their dis-
charge from the Ebola treatment centre. Biological-based therapy (n = 141, 86.5%) with was
the most common T&CM treatment modality used among T&CM users. The most frequent
reasons put forward by survivors for using T&CM include: the high cost of conventional medi-
cine (n = 84, 51.5%); the alignment between T&CM and their own beliefs and faith (n = 84,
51.5%); and the perception that conventional medicine is not always effective, or was not at all
effective, for their condition or the perception that T&CM is more effective than conventional
medicine for their condition (n = 76, 47.2%). On the other hand, the main reasons for not
using T&CM among non-users include their perceptions that T&CM is ineffective (n = 116,
59.5%) and advice from their healthcare provider not to use T&CM (n = 89,45.6%). EVD sur-
vivors mentioned other reasons (n = 63, 32.3%) for not using T&CM and these include not
Health care utilization among Ebola survivors in Sierra Leone
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Table 1. Socio demographic characteristics of EVD survivors (N = 358).
Characteristics Variables n (%)












Religious Affiliation Christianity 92(25.7)
Islam 266(74.3)




Financial management It is impossible/ Difficult all the time 110(30.7)
difficult some time 238(66.5)
Not too bad 10(2.8)
Monthly income (Leones) Less than 500,000 252(70.4)
500,000 - 1million 94(26.3)
>1million 12(3.4)
Residential Area Urban 219(61.2)
Rural 139(38.8)
Region Northern region (Bambali district) 120(33.5)
Southern region (Bo district) 55(15.4)
Eastern region (Kenema district) 62(17.3)
Western Area 121(33.8)
Employment status before being infected with Ebola Full time 230(64.2)
Part time 19(5.3)
Casual/Temporal 17(4.7)
Looking for job 26(7.3)
not in paid work force 66(18.4)
Employment status after surviving Ebola Full time 164(45.8)
Part time 16(4.5)
Casual/Temporal 19(5.3)
Looking for job 100(27.9)
not in paid work force 59(16.5)
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used to taking T&CM and T&CM is without standardised dose. Close to half of T&CM users
(n = 75, 46.0%) were using T&CM irregularly while family (n = 101, 62.0%) followed by friends
(n = 38, 23.3%) were identified as the main source of recommendations to use T&CM.
Abdominal pain (n = 49, 30.1%) followed by arthralgia (n = 46, 28.2%) and back pain (n = 43,
26.4%) were the most cited post–Ebola indications for T&CM use while malaria (n = 32,
19.6%) was the most cited non-post-Ebola indications for T&CM use.
Disclosure of T&CM use to healthcare providers
As shown in Table 6, more than three-quarters of T&CM users (n = 135, 82.8%) failed to dis-
close their use of T&CM to their healthcare providers. The main reason for non-disclosure
was the fact that healthcare providers failed to ask about T&CM use during consultation
(n = 77, 57.0%). Among those who disclosed their T&CM use status, the main reasons for dis-
closure were wanting healthcare providers to fully understand their health status
(n = 15,53.6%) and being asked by healthcare providers about their T&CM use (n = 15,53.6%).
Half of those who disclosed their T&CM use status considered their healthcare provider’s reac-
tion to be discouraging (n = 14, 50.0%).
Discussion
Our paper reports the findings of the first study (since the first Ebola outbreak more than 40
years ago) to examine the pattern of health care utilisation and T&CM use among Ebola survi-
vors experiencing post-Ebola sequelae. The finding of this study suggests that Ebola survivors
are seeking a myriad of healthcare options (conventional medicine and T&CM) and that medi-
cal pluralism is common in addressing their healthcare needs. Although the majority of survi-
vors seek care from a conventional health provider, at the same time, we observed that a
Table 1. (Continued)
Characteristics Variables n (%)
Known Chronic disease Yes 46(12.8)
No 312(87.2)








Back pain Yes 179(50.0)
No 179(50.0)
Abdominal pain Yes 132(36.9)
No 226(63.1)
Auditory symptoms Yes 61(17.0)
No 297(83.0)
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considerable number either self-medicate with either/or both conventional medicine and
T&CM or seek care from a private pharmacy, religious leader (pastor/Imam in church/mos-
que) or from a T&CM practitioner. Although no comparable data regarding healthcare seek-
ing behaviour among Ebola survivors exist in the literature, our findings are in line with the
nature of health seeking behaviour reported in other emerging and re-emerging infectious dis-
eases such as malaria among children in Sierra Leone,[7, 8], HIV/AIDS patients in South
Africa[35] and tuberculosis patients in rural Nigeria.[36]. The use of multiple healthcare
approaches may be a reflection of the high cost and the perceived lack of effectiveness of cur-
rent allopathic treatments as well as the absence of specialised care for post–Ebola sequelae.
For instance, our study revealed that EVD survivors’ perception of conventional medicine not
being effective and unaffordable were the main reasons for survivors seeking T&CM
treatment.
Our analyses shows that close to half of Ebola survivors had self-prescribed T&CM products
and/or used the services of a T&CM practitioner since post–ETC discharge. In comparison
with other emerging and re-emerging infectious diseases, our reported T&CM prevalence is
similar to the average prevalence of T&CM product and practitioner use among HIV/AIDS
Table 2. Prevalence of conventional and T&CM health service utilization among EVD survivors.
Conventional and T&CM health service
utilization
Type of health care utilized n (%) Reasons for seeking particular health care
model
Self- medicated with Conventional medicine 255(71.2) Managing my symptoms for my Ebola
sequelae(191/255)
Seeking a cure for my Ebola sequelae (94/255)
Health concern unrelated to Ebola
complication (12/255)
Self-medicated with traditional and complementary medicine 107(29.9) Managing my symptoms for my Ebola
sequelae(54/107)
Seeking a cure for my Ebola sequelae (32/107)
Health concern unrelated to Ebola
complication (37/107)
Concurrent use of both conventional and traditional
complementary medicine
62(17.3) Managing my symptoms for my Ebola
sequelae(31/62)
Seeking a cure for my Ebola sequelae (28/62)
Health concern unrelated to Ebola
complication (4/62)
Visited a healthcare provider (doctor, nurse at hospital, Ebola
Survivor clinic etc.)
308(86.0) Managing my symptoms for my Ebola
sequelae (94/308)
Seeking a cure for my Ebola sequelae (251/
308)
Health concern unrelated to Ebola
complication (19/308)
Visited a private pharmacy outlet 141(39.4) Managing my symptoms for my Ebola
sequelae (60/141)
Seeking a cure for my Ebola sequelae (75/141)
Health concern unrelated to Ebola
complication (10/141)
Visited a spiritual house (pastor/Imam in church/mosque) 73(20.4) Managing my symptoms for my Ebola
sequelae (20/73)
Seeking a cure for my Ebola sequelae (47/73)
Health concern unrelated to Ebola
complication (6/73)
Visited a traditional medicine practitioner (native doctor,
herbalist)
41(11.5) Managing my symptoms for my Ebola
sequelae(4/41)
Seeking a cure for my Ebola sequelae (30/41)
Health concern unrelated to Ebola
complication(9/41)
https://doi.org/10.1371/journal.pone.0223068.t002
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Table 3. Association between T&CM treatment use and sociodemographic variables.
Characteristics Variables Users n(%) Non-users n(%) p-value
Age group 18–33 years 91(55.8) 103(52.8) 0.760
34–49 years 60(36.8) 74(37.9)
� 50 years 12(7.4) 18(9.2)
Sex Male 64(39.3) 71(36.4) 0.579
female 99(60.7) 124(63.6)




Religious Affiliation Christianity 44(27.0) 48(24,6) 0.608
Islam 119(73.0) 147(75.4)
Marital Status Single 45(27.6) 55(28.2) 0.258
Married/Cohabitating 72(44.2) 99(50.8)
Divorced/Separated/widowed 46(28.2) 41(21.0)
Financial management It is impossible/ Difficult all the time 58(35.6) 52(26.7) 0.153
difficult some time 100(61.3) 138(70.8)
Not too bad 5(3.1) 5(2.6)
Monthly income (Leones) Less than 500,000 117(71.8) 135(69.2) 0.773
500,000 - 1million 40(24.5) 54(27.7)
>1million 6(3.7) 6(3.1)
Residential Area Urban 94(57.7) 125(64.1) 0.214
Rural 69(42.3) 70(35.9)
Region Northern region (Bambali district) 33(20.2) 87(44.6) <0.001
Southern region (Bo district) 24(14.7) 31(15.9)
Eastern region (Kenema district) 21(12.9) 41(21.0)
Western Area 85(52.1) 36(18.5)
Employment status after surviving Ebola Full time 73(44.8) 91(46.7) 0.292
Part time 8(4.9) 8(4.1)
Casual/Temporal 5(3.1) 14(7.2)
Looking for job 52(31.9) 48(24.6)
not in paid work force 25(15.3) 34(17.4)
Current perceived health status Very good/Good 23(14.1) 73(37.4) <0.001
Fair/poor 140(85.9) 122(62.6)
Duration(months) since discharged from ETC �3 years 18(11.0) 9(4.6) 0.022
>3years 145(89.0) 186(95.4)
Known Chronic disease Yes 19(11.7) 27(13.8) 0.538
No 144(88.3) 168(86.2)
Arthralgia Yes 147(90.2) 172(88.2) 0.550
No 16(9.8) 23(11.8)
Headache Yes 118(72.4) 154(79.0) 0.147
No 45(27.6) 41(21.0)
Ocular Symptoms Yes 100(61.3) 106(54.4) 0.187
No 63(38.7) 89(45.6)
Fatigue Yes 76(46.6) 105(53.8) 0.174
No 87(53.4) 90(46.2)
Back pain Yes 85(52.1) 94(48.2) 0.458
No 78(47.9) 101(51.8)
(Continued)
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patients in sub-Saharan Africa[2] but slightly lower than the frequency of T&CM use for the
treatment of malaria among Sierra Leonean adults.[9] Also, the reasons cited in our study for
using T&CM treatment are in line with previous studies on T&CM use in Sierra Leone[3, 5, 6,
9, 37] and across Africa,[2] where T&CM is reported to be highly accessible, affordable and
culturally accepted. Within the Ebola virus disease context, the high use of T&CM among sur-
vivors may be explained in that current biomedical care as provided to survivors with post-
Ebola complications is proving inadequate given that the nature and mechanism of these
sequalae are still not well understood.[38] Also, the conventional health care services currently
provided in West Africa are dominated by general health assessments and largely devoid of
specialised care, especially for those survivors experiencing severe and long term sequalae[27].
The widespread use of T&CM together with conventional medicine among EVD survivors
in our study indicates that the Sierra Leone free healthcare initiative (FHCI) has not been effec-
tive in preventing EVD survivors from using traditional and complementary health
Table 3. (Continued)
Characteristics Variables Users n(%) Non-users n(%) p-value
Abdominal pain Yes 65(39.9) 67(34.4) 0.281
No 98(60.1) 128(65.6)
Auditory symptoms Yes 38(23.3) 23(11.8) 0.004
No 125(76.7) 172(88.2)
Skin Disorders Yes 29(17.8) 26(13.3) 0.244
No 134(82.2) 169(86.7)
Alopecia Yes 24(14.7) 14(7.2) 0.021
No 139(85.3) 181(92.8)
https://doi.org/10.1371/journal.pone.0223068.t003
Table 4. Predictors of T&CM treatment use among EVD survivors using backwards stepwise binary logistic regression.
Characteristics Variables Adjusted ORa 95% CIb p-value
Current perceived health status Very good/Good 1
Fair/poor 4.08 2.22–7.50 <0.001
Region Western Area 1
Northern region (Bambali district) 0.14 0.08–0.27 <0.001
Southern region (Bo district) 0.37 0.18–0.78 0.008
Eastern region (Kenema district) 0.19 0.09–0.40 <0.001
Duration(Years) since discharged from ETC >3years 1
�3 years 3.14 1.13–8.73 0.028
Arthralgia(Joint pain) No 1
Yes 2.52 1.11–5.69 0.026
Headache No 1
Yes 0.48 0.27–0.87 0.014
Abdominal Pain No 1
Yes 1.57 0.94–2.62 0.084
Auditory symptoms No 1
Yes 1.80 0.94–3.46 0.077
Fatigue No 1
Yes 0.61 0.37–1.00 0.054
aOR = Odd ratio,
b CI = Confidence interval
https://doi.org/10.1371/journal.pone.0223068.t004
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Table 5. Pattern of T&CM treatment use.
Variables n (%)
T&CM treatment use Yes 163(45.5)
No 195(54.5)
Type of T&CM treatment use n = 163- multiple
choice
Biological based therapy 141(86.5)





Others (scarification, local surgery) 10(6.1)
Reasons for using T&CM treatment n = 163- multiple
choice
Conventional medicine is not always effective/ was not effective for my condition/
T&CM effective than conventional medicine for my condition
76(47.2)
T&CM is quick or fast in action 53(32.5)
I cannot afford to buy conventional medicine because it is too expensive 84(51.5)
T&CM is natural 56(34.4)
Conventional medicine has side effects 10(6.1)
T&CM is more is more in keeping with one’s belief and faith 84(51.5)
To promote and maintain one’s health 60(36.8)
I want to have control over my health 18(11.0)
Others 10(6.1)
Reasons for not using T&CM N = 195- multiple
choice
I don’t believe it works 116(59.5)
My healthcare provider advised not use T&CM 89(45.6)
Caused side effects 56(28.7)
Others 63(32.3)
Perceived adverse effect of T&CM treatment n = 163 Dizziness 15(9.2)
Drowsiness 9(5.5)
Itching 17(10.4)
Nausea and vomiting 46(28.2)
Others (headache, dysuria, weakness) 3(1.8)
No side adverse effect 68(41.7)
Frequency of T&CM use n = 163 Irregular use 75(46.0)
Daily 32(19.6)
More than once per week 26(16.0)
Weekly 30(18.4)




Media(radio or TV) 5(3.1)
Health care provider 5(3.1)
Neighbour 17(10.4)
Traditional medicine practitioner 33(20.2)
Myself 14(8.6)
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approaches. The FHCI policy was originally designed for pregnant women, lactating mothers
and under-five children[39] and EVD survivors in Sierra Leone have recently being included
as beneficiaries.[40] Interestingly, recent Sierra Leonean studies indicate that T&CM use is
common among pregnant women and lactating mothers seeking care in public healthcare
facilities [3, 4]. This shows that the high cost of treatment that impedes access to biomedical
care is not the only driver for T&CM use among EVD survivors including pregnant women
and lactating mothers but a combination of social, cultural and health system factors may play
a role. Also, given that individuals with chronic complex diseases are seeking more holistic/
person-centred care [41, 42], it may be that survivors are seeking other health services if the
available health care is not meeting these other needs. Although our study reports some of the
reasons for T&CM use among EVD survivors, a qualitative study is needed to offer a deeper
understanding of the reasons why EVD survivors still seek traditional and complementary
healthcare even when medical care is free. Given T&CM is highly perceived as effective and in
line with people’s cultural and religious values[2], the use of T&CM among survivors who seek
conventional care in our study also indicates the need for an open discussion between T&CM
users and healthcare providers about the benefits and risks of T&CM so that survivors can
make an informed decision.
The high use of T&CM and the pluralistic health seeking behaviour among Ebola survivors
may present challenges for post-Ebola care in Sierra Leone. Such challenges include adverse
effects resulting from herbal-drug interactions and compromised safety due to herbal medi-
cine contamination can negatively affect the outcome of care received by Ebola survivors.
Also, the fact that our study reports that most survivors use T&CM irregularly and, that the
decision to use T&CM was influenced by families or friends raises concern with regards the
Table 5. (Continued)
Variables n (%)
Menstrual problems[Amenorrhea(7), heavy menstrual bleeding(2),
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effective, judicious use of T&CM among Ebola survivors. Much information on T&CM from
such non-professional sources may well be incorrect and lacking an evidence-base and, as
such, may potentially undermine patient health by enhancing therapeutic failure of conven-
tional medicine,[43] conventional medicine toxicity[44] and non-adherence to pharmaceuti-
cals [45]. Thus, the potential for direct and indirect risks associated with medical pluralism
emphasizes the need to educate Ebola survivors on the risks and benefits of commonly used
T&CM in Sierra Leone.
As reported in previous T&CM use studies in Sierra Leone[3, 5, 6] and across Africa[2], the
fact that most survivors in our study failed to disclosed their T&CM use status to their health-
care provider is a cause for concern. Such non-disclosure highlights largely, the absence of
communication between healthcare providers and Ebola survivors regarding T&CM. Fear of
being judged or not receiving care as well as lack of inquiry from healthcare providers were
cited as the main reasons for non-disclosure amongst our study participants, and this mirrors
findings of studies conducted among general and sub-health populations across Africa.[2]
Given that there is an established relationship between non-disclosure of T&CM use and
patient safety,[46] educational interventions targeting healthcare practitioners providing care
to survivors will be useful in attracting attention and improving knowledge about T&CM use
in the care for Ebola survivors[47]. Even in cases, where survivors disclose their T&CM use,
our finding indicates that healthcare providers’ response was discouraging mirroring findings
from a study conducted among HIV/AIDS patients in South Africa[48]. This speaks to the fact
that the nature of communication between healthcare providers and Ebola survivors was often
devoid of respect and empathy. Effective communication around T&CM use with Ebola survi-
vors is essential to optimizing their care. Thus, it is important that healthcare providers be
Table 6. Disclosure of T&CM use to healthcare providers.
Disclosure of TCAM use n = 163 Yes 28(17.2)
No 135(82.8)
If YES, reasons for disclosure N = 28-
multiple choice
I wanted them to fully understand my health status 15(53.6)
I was concerned about drug interactions with the
traditional and complementary medicine I was using
7(25.0)
I thought they might know something about traditional and
complementary medicine
3(10.7)
They asked me about my use of traditional and
complementary medicine use
15(53.6)
If YES, What was the reaction of the




If NO, what were the reasons for non-
disclosure N = 135- multiple choice
They did not ask me about my traditional and
complementary medicine use
77(57.0)
I did not think it was important 43(31.9)
I did not think they would understand my choice 9(6.7)
I was worried they would judge me or respond negatively/
will not provide the care I need
63(46.7)
Traditional and complementary medicine is safe and so
they did not need to know
5(3.7)
There was not enough time in the consultation 7(5.2)
I felt uncomfortable discussing it with them 6(4.4)
I did not think they would know anything about traditional
and complementary medicine
12(8.9)
Others(My T&CM use is something personal) 1(0.7)
https://doi.org/10.1371/journal.pone.0223068.t006
Health care utilization among Ebola survivors in Sierra Leone
PLOS ONE | https://doi.org/10.1371/journal.pone.0223068 September 27, 2019 14 / 19
mindful that Ebola survivors are potential T&CM users and be proactive in initiating respect-
ful conversations around survivors’ T&CM use.
Regression analyses of our data show that Ebola survivors who consider their health to be
poor/fair were more likely to use T&CM. The correlation between perceived poor health of
EVD survivors and their use of T&CM use is in line with results from a study of T&CM use
among the general population in 32 countries around the world.[49] The relationship between
EVD survivors’ perceived poor health and their use of T&CM may be due to Ebola survivors’
unmet needs. For example, Ebola survivors in our study cited the ineffectiveness of conven-
tional therapies to treat post-Ebola sequelae as one of the reasons for using T&CM in our
study. The need for holistic and person-centred care as it has been reported among patients
with chronic conditions [41, 50], may also explain why survivors who perceived their health to
be poor are likely T&CM users. Ebola survivors who discharged from an Ebola treatment cen-
tre (ETC) three years or less to the time of data collection compared to those discharged more
than three years prior to data collection were more likely to use T&CM. Such a relationship
may be explained by the survivors’ increased utilization of various healthcare options particu-
larly T&CM[51] given that survivors who were recently discharged from ETC are known to
experience an increased number of severe post–Ebola sequalae[52]. Analyses of our data also
indicated that EVD survivors who presented with arthralgia (joint pain) were more likely to
use T&CM. It is possible that EVD survivors may decide to try alternate health approaches
when the joint pain becomes recurrent or persistent after using conventional medicine. Fur-
ther research is required to explore the reasons why survivors who perceive their health to be
poor/fair, discharged from ETC three years or less and presented with arthralgia are likely to
be T&CM users. Nevertheless, our findings have indicated that perceived health status, post-
ETC discharge time and arthralgia are potential predictors for T&CM use among Ebola survi-
vors and, that healthcare providers should take note of such details when identifying potential
T&CM users among Ebola survivors.
Our study reports musculoskeletal problems (abdominal pain, arthralgia and back pain) as
the most common post–Ebola sequalae among survivors who use T&CM. Such a finding is
not surprising given that musculoskeletal problems have been reported to be common among
Ebola survivors in Sierra Leone[53, 54]and that T&CM use is widespread in people with
chronic musculoskeletal disorders[55]. As reported in our study, reasons cited in the literature
to justify the use of T&CM for musculoskeletal problems include its perceived effectiveness,
low cost, accessibility, alignment with patient’s cultural and spiritual beliefs of illness and
health and dissatisfaction with conventional healthcare[41]. Our analyses also indicate that
malaria was the most common non-post-Ebola indication for T&CM use among Ebola survi-
vors. Malaria is a public health priority in Sierra Leone due to its high burden among the gen-
eral population and especially among children[56]. Increased healthcare utilization due to
malaria have been reported[56], and the use of T&CM which has been reported in the general
Sierra Leonean population is certainly one of the myriad of healthcare approaches used to
treat malaria[7–9]. The use of T&CM for post–Ebola musculoskeletal problems and malaria
among survivors have significant implications for policy and practice with regards to the need
for inclusion of T&CM as part of routine clinical consultation and the need for appropriate
T&CM regulation.
Limitations
Our study findings should be interpreted with the following limitations in mind. First, the data
collected was based on self-report, which is a risk factor to responder and recall bias. Also, no
cause-effect relationship can be inferred because of the cross-sectional design that we
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employed in this study. In addition, our study did not provide any information on survivors’
health outcomes due to T&CM use in particular. We excluded survivors who presented with
serious post-ebola complications such as memory loss, hearing loss or acute severe emotional
distress. However, this is the first nationwide survey that looks at healthcare utilization among
Ebola survivors with an emphasis on their T&CM use and, therefore, our findings are repre-
sentative of the wider population of Ebola survivors of Sierra Leone. In addition, our study will
serve as a basis for future research in this area and other emerging and re-emerging infectious
diseases outbreaks.
Conclusion
Ebola survivors in Sierra Leone utilise a variety of health approaches including T&CM to
address their post-discharge healthcare challenges. Thus, it is essential that researchers, health
policymakers and healthcare providers consider T&CM in their research, policy formulation
and implementation and routine practice with regards Ebola survivors.
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